What releases are upcoming from the Drug Enforcement Administration on Oct. 11

Home
»
Stories
»
2022
»
October

What releases are upcoming from the Drug Enforcement Administration on Oct. 11

Justice

ORGANIZATIONS IN THIS STORY

U.S. Department Of Justice (DOJ) | U.S. Department of Justice | Office Of The Federal Register

By DOJ Newswire

Oct 7, 2022

The US public can gain insight into what releases the federal agencies will publish, through the Public Inspection Document Search. The following releases are redacted until publication but still indicate what agencies are addressing and advocating for.

Agency	Release Title	Pages	Document Number
Drug Enforcement Administration	Importer, Manufacturer or Bulk Manufacturer of Controlled Substances; Application, Registration, etc.: Curia Missouri, Inc.	2	2022-21931
Drug Enforcement Administration	Importer, Manufacturer or Bulk Manufacturer of Controlled Substances; Application, Registration, etc.: Cambrex High Point, Inc.	2	2022-21933
Drug Enforcement Administration	Importer, Manufacturer or Bulk Manufacturer of Controlled Substances; Application, Registration, etc.: Curia New York, Inc.	2	2022-21934
Drug Enforcement Administration	Importer, Manufacturer or Bulk Manufacturer of Controlled Substances; Application, Registration, etc.: Curia Wisconsin, Inc.	2	2022-21935
Drug Enforcement Administration	Importer, Manufacturer or Bulk Manufacturer of Controlled Substances; Application, Registration, etc.: Groff NA Hemplex, LLC	3	2022-21939
Drug Enforcement Administration	Importer, Manufacturer or Bulk Manufacturer of Controlled Substances; Application, Registration, etc.: Chattem Chemicals, Inc.	2	2022-21940
Drug Enforcement Administration	Importer of Controlled Substances Application: VICI Health Sciences, LLC	2	2022-21942
Drug Enforcement Administration	Bulk Manufacturer of Controlled Substances Application: Eli-ElSohly Laboratories	2	2022-21945
Drug Enforcement Administration	Importer, Manufacturer or Bulk Manufacturer of Controlled Substances; Application, Registration, etc.: Hybrid Pharma	2	2022-21946